Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C15H19N5 |
| Molecular Weight | 269.3449 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](N\C(NC#N)=N\C1=CC=C(C=C1)C#N)C(C)(C)C
InChI
InChIKey=PGYDRGZVXVVZQC-LLVKDONJSA-N
InChI=1S/C15H19N5/c1-11(15(2,3)4)19-14(18-10-17)20-13-7-5-12(9-16)6-8-13/h5-8,11H,1-4H3,(H2,18,19,20)/t11-/m1/s1
| Molecular Formula | C15H19N5 |
| Molecular Weight | 269.3449 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://adisinsight.springer.com/drugs/800016162
Sources: https://adisinsight.springer.com/drugs/800016162
Naminidil, a potassium channel opener, was under development with Bristol-Myers Squibb as a topical treatment for androgenetic alopecia. The research has been discontinued.
Originator
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 05:47:43 GMT 2025
by
admin
on
Wed Apr 02 05:47:43 GMT 2025
|
| Record UNII |
7K50VT05OD
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29707
Created by
admin on Wed Apr 02 05:47:43 GMT 2025 , Edited by admin on Wed Apr 02 05:47:43 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
8230
Created by
admin on Wed Apr 02 05:47:43 GMT 2025 , Edited by admin on Wed Apr 02 05:47:43 GMT 2025
|
PRIMARY | |||
|
7K50VT05OD
Created by
admin on Wed Apr 02 05:47:43 GMT 2025 , Edited by admin on Wed Apr 02 05:47:43 GMT 2025
|
PRIMARY | |||
|
300000034288
Created by
admin on Wed Apr 02 05:47:43 GMT 2025 , Edited by admin on Wed Apr 02 05:47:43 GMT 2025
|
PRIMARY | |||
|
NN-07
Created by
admin on Wed Apr 02 05:47:43 GMT 2025 , Edited by admin on Wed Apr 02 05:47:43 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105160
Created by
admin on Wed Apr 02 05:47:43 GMT 2025 , Edited by admin on Wed Apr 02 05:47:43 GMT 2025
|
PRIMARY | |||
|
220641-11-2
Created by
admin on Wed Apr 02 05:47:43 GMT 2025 , Edited by admin on Wed Apr 02 05:47:43 GMT 2025
|
PRIMARY | |||
|
C77076
Created by
admin on Wed Apr 02 05:47:43 GMT 2025 , Edited by admin on Wed Apr 02 05:47:43 GMT 2025
|
PRIMARY | |||
|
158438
Created by
admin on Wed Apr 02 05:47:43 GMT 2025 , Edited by admin on Wed Apr 02 05:47:43 GMT 2025
|
PRIMARY | |||
|
DTXSID00176552
Created by
admin on Wed Apr 02 05:47:43 GMT 2025 , Edited by admin on Wed Apr 02 05:47:43 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
RACEMATE -> ACTIVE ENANTIOMER | |||
|
|
ENANTIOMER -> ENANTIOMER |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |